W.R. Berkley Corp’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Buy
272,950
+99,420
+57% +$1.05M 0.16% 135
2025
Q4
$1.82M Hold
173,530
0.09% 159
2025
Q3
$1.79M Hold
173,530
0.1% 147
2025
Q2
$1.78M Hold
173,530
0.09% 150
2025
Q1
$1.75M Buy
+173,530
New +$1.74M 0.1% 111

Other funds holding TDAC

W.R. Berkley Corp's TDAC Position: Q1 2026 in Review

W.R. Berkley Corp increased its Translational Development Acquisition Corp (TDAC) stake by 57% in Q1 2026, buying an estimated $1.05M and bringing the position to 272,950 shares worth $2.89M. The position accounts for 0.16% of the portfolio, ranked #135.

W.R. Berkley Corp first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • W.R. Berkley Corp held 272,950 shares of Translational Development Acquisition Corp worth $2.89M as of Q1 2026.
  • W.R. Berkley Corp bought 99,420 Translational Development Acquisition Corp shares in Q1 2026, an estimated $1.05M.
  • Translational Development Acquisition Corp made up 0.16% of W.R. Berkley Corp's portfolio in Q1 2026, its #135 holding.
  • W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.